Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT00764972
Title Phase IB/II Trial Combining Vinorelbine With Sorafenib as First-Line Treatment in Patients With Metastatic Breast Cancer
Recruitment Unknown status
Gender female
Phase Phase Ib/II
Variant Requirements No
Sponsors McGill University
Indications
Therapies
Age Groups: adult
Covered Countries CAN


No variant requirements are available.